Thank you for attending Translational Science 2016!
We hope you enjoyed your time with us in Washington, DC! Please see below for a press release describing the event.
ACTS, AFMR, and CRF Jointly Host Successful Translational Science Annual Meeting
WASHINGTON, DC – April 15, 2016 – The Association for Clinical and Translational Science (ACTS), the American Federation for Medical Research (AFMR), and the Clinical Research Forum (CRF) hosted their annual meeting, Translational Science 2016, from Wednesday, April 13 to Friday, April 15.
This year’s event drew a record-breaking 940 attendees, comprised of trainees, researchers, and federal program officers. The three associations are proud to note that 597 of these attendees were at the event for the first time.
“We see success in our work when we are provided opportunities to collaborate and innovate by sharing our research,” said ACTS President Rebecca Jackson. “The Translational Science Annual Meeting continues to be the best forum for investigators from all disciplines, at all levels of experience, to achieve just that.”
Highlights of the event included plenary presentations from seven speakers:
- Claire Pomeroy, MD, MBA, President of the Albert and Mary Lasker Foundation
- Jacob Corn, PhD, Managing Director and Scientific Director of the Innovative Genomics Initiative and Faculty at UC Berkeley
- Kathy Hudson, PhD, Deputy Director for Science, Outreach and Policy at NIH
- Chris Austin, MD, Director of National Center for Advancing Translational Sciences
- Josie Briggs, MD, Director of the National Center for Complementary and Integrative Health
- David G. Nathan, MD, President Emeritus, Dana-Farber Cancer Institute, Robert A. Stranahan Distinguished Professor of Pediatrics and Professor of Medicine, Harvard Medical School
- William R. Skach, MD, Cystic Fibrosis Foundation Senior Vice President for Research Affairs.
“The AFMR continues its annual participation and support of the Translational Science meeting, in collaboration with ACTS and CRF, to bring symposia and seminars of wide appeal. These sessions continue to be highly rated every year attracting ever increasing numbers of attendees,” said Drs. Amir Zeki and Armand Krikorian, the past and current presidents of AFMR. “We are proud to work collaboratively with our colleagues from the other two societies with the shared vision of improving biomedical research and the health of our nation.”
The meeting also included 35 concurrent sessions featuring over 90 speakers, including FDA Commissioner Robert Califf, MD. More than 440 poster abstracts were showcased over three days, with 30 abstracts presented orally. Additionally, more than 100 attendees representing 27 states visited Capitol Hill to advocate for translational science research.
"The Clinical Research Forum is proud to partner with ACTS and AFMR on this outstanding event,” said Dr. Harry Selker, Chairman of the Clinical Research Forum. “I am impressed each year with the caliber of the research presented and the focus on translation of research into impact on health. We look forward to being part of another excellent Translational Science Meeting in 2017.”
Thanks to generous support from the Burroughs Wellcome Fund, 40 scholar and trainee attendees were awarded a $500 travel grant to attend Translational Science 2016. We would also like to thank our event sponsors for their overall support of the event:
- Burroughs Wellcome Fund
- Journal of Investigative Medicine
- Science Translational Medicine
- Translational Vision Science & Technology
ACTS AFMR, and CRF have already begun planning Translational Science 2017, to be held April 18 - 21, 2017 at the Washington Marriott Wardman Park in Washington, DC. Registration for Translational 2017 is expected to open in December 2016.
About the Association for Clinical and Translational Science (ACTS)
ACTS was specifically created to address the needs of the clinical and translational science community. ACTS members are part of a community of over 6,000 individuals from 58 institutions, who receive many exciting benefits to help increase their presence and strengthen the voice of clinical and translational science. Learn more at www.actscience.org.
About the American Federation for Medical Research (AFMR)
Established in 1940, AFMR is an international multi-disciplinary association of scientists engaged in all areas of biomedical and patient-oriented clinical, translational, and laboratory research. The organization’s mission is to develop and mentor future leaders in medical research, while encouraging public, private and governmental investment in the development of these individuals. AFMR Members are located at government facilities, medical centers, research institutions, and private industry in all 50 states and throughout the world. Learn more at www.afmr.org.
About the Clinical Research Forum (CRF)
The Clinical Research Forum provides leadership to the national clinical and translational research enterprise. CRF acts as a convener to provide continuing opportunities and promote the standards for sharing best practices and debating substantive scientific and policy issues facing the field while providing leadership to influence public policy, increase funding, broaden public knowledge, and expand support for all forms of clinical research nation-wide. Learn more at www.clinicalresearchforum.org.